Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and Interleukin 2
- 1 February 1991
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 62 (1), 25-31
- https://doi.org/10.1007/bf01714980
Abstract
This study was designed to investigate acute effects of various doses of the cytokines IFN-alpha, IFN-gamma Interleukin 2 and tumor necrosis factor alpha on white blood cell differential counts. Before initiation of phase II trials, a dose-determination phase was performed, where three different dose levels of each cytokine were applied as a single dose. White blood cell differential counts were assessed immediately before and 2, 12, 24, 48 and 168 h after injection. Patients enrolled suffered from metastatic cancer or chronic active hepatitis. In addition, IFN-alpha was administered to five healthy volunteers. Results indicate that cytokines cause rapid and transient changes in the numbers of leukocyte subsets. Hematologic changes were cell-type- and cytokine-specific: transient lymphopenia was observed after administration of all four cytokines, reaching a nadir 12 to 24 h after subcutaneous injection. Administration of TNF-alpha and IFN-gamma also caused transient monocytopenia. Neutrophilia developed after administration of Interleukin 2, IFN-alpha and TNF-alpha. We conclude that cytokines play a key role in the regulation of peripheral blood cell traffic by their capacity to influence homing patterns of peripheral blood leukocytes.Keywords
This publication has 37 references indexed in Scilit:
- Tumour Necrosis Factor in Hepatosplenic SchistosomiasisScandinavian Journal of Immunology, 1990
- The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognitionImmunology Today, 1989
- Acute Effects of Single Doses of Recombinant Interferon-γ on Blood Cell Counts and Lymphocyte Subsets in Patients with Advanced Renal Cell CancerJournal of Interferon Research, 1989
- Immunologic study of human recombinant interleukin-2 (low dose) in patients with advanced renal cell carcinomaUrology, 1989
- Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells.The Journal of cell biology, 1988
- Interleukin-2: Inception, Impact, and ImplicationsScience, 1988
- The function of human intercellular adhesion molecule‐1 (ICAM‐1) in the generation of an immune responseEuropean Journal of Immunology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Tumor Necrosis Factor (TNF)Science, 1985
- LEUKOKINETIC STUDIES. IV. THE TOTAL BLOOD, CIRCULATING AND MARGINAL GRANULOCYTE POOLS AND THE GRANULOCYTE TURNOVER RATE IN NORMAL SUBJECTS*Journal of Clinical Investigation, 1961